Advicenne SA (FR:ALDVI) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Advicenne SA reported a 28% increase in Sibnayal gross sales reaching €1.25 million for the first half of 2024, alongside progress towards operating breakeven, and a stable cash position of €2.0 million with visibility into the first quarter of 2025. The company is also optimistic about its regulatory and commercial prospects in the U.S. for its ADV7103 treatment. Overall, Advicenne saw a 10% rise in gross sales to €2.46 million, and an improved operating loss of €2.84 million compared to the previous year.
For further insights into FR:ALDVI stock, check out TipRanks’ Stock Analysis page.
